Oncogenic human papillomavirus-infected immature metaplastic cells and cervical neoplasia

American Journal of Surgical Pathology

Volumn 38, Issue 4, 2014, Pages 470-479

  Van Der Marel, Jacolien ^a   Van Baars, Romy ^a   Alonso, Inmaculada ^e   Del Pino, Marta ^e   Van De Sandt, Miekel ^a   Lindeman, Jan ^a   Ter Harmsel, Bram ^b   Boon, Mathilde ^c   Smedts, Frank ^d   Ordi, Jaume ^f   Torné, Aureli ^e   Jenkins, David ^a   Quint, Wim ^a  

^a DDL DIAGNOSTIC LABORATORY   (Netherlands)

^b Rooseveltkliniek   (Netherlands)

^c Leids Cytologisch Pathologisch Laboratorium   (Netherlands)

^d REINIER DE GRAAF HOSPITAL   (Netherlands)

^e INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^f CENTRE FOR RESEARCH IN ENVIRONMENTAL EPIDEMIOLOGY CREAL   (Spain)

Author keywords

Atypical immature metaplasia; Cervical intraepithelial neoplasia; Human papillomavirus; Immature metaplasia; Laser capture microdissection; Squamocolumnar junction

Indexed keywords

ARTICLE; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; LASER CAPTURE MICRODISSECTION; METAPLASIA; PAPANICOLAOU TEST; PAPILLOMAVIRUS INFECTION; PATHOLOGY; POLYMERASE CHAIN REACTION; PRECANCER; UTERINE CERVIX; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX TUMOR; VAGINA SMEAR; VIROLOGY;

CERVICAL INTRAEPITHELIAL NEOPLASIA; CERVIX UTERI; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LASER CAPTURE MICRODISSECTION; METAPLASIA; PAPANICOLAOU TEST; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; PRECANCEROUS CONDITIONS; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 84897028540     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0000000000000174     Document Type: Article

References (52)

1. Jarmulowicz MR, Jenkins D, Barton SE, et al. Cytological status and lesion size: A further dimension in cervical intraepithelial neoplasia. Br J Obstet Gynaecol. 1989;96:1061-1066.
2. Herfs M, Vargas SO, Yamamoto Y, et al. A novel blueprint for "top down" differentiation defines the cervical squamocolumnar junction during development, reproductive life, and neoplasia. J Pathol. 2013;229:460-468.
3. Herfs M, Yamamoto Y, Laury A, et al. A discrete population of squamocolumnar junction cells implicated in the pathogenesis of cervical cancer. Proc Natl Acad Sci USA. 2012;109:10516-10521.
4. Galani E, Christodoulou C. Human papilloma viruses and cancer in the post-vaccine era. Clin Microbiol Infect. 2009;15:977-981.
5. Bosch FX, Lorincz A, Munoz N, et al. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol. 2002;55:244-265.
6. Baseman JG, Koutsky LA. The epidemiology of human papillomavirus infections. J Clin Virol. 2005;32(suppl 1):S16-S24.
7. Bonfiglio TA, Patten SF. Histopathologic spectrum of benign proliferative and intraepithelial neoplastic reactions of the uterine cervix. J Reprod Med. 1976;16:253-262.
8. Koss LG. Detection of carcinoma of the uterine cervix. JAMA. 1972;222:699-700.
9. Schiffman M, Castle PE, Jeronimo J, et al. Human papillomavirus and cervical cancer. Lancet. 2007;370:890-907.
10. Herfs M, Parra-Herran C, Howitt BE, et al. Cervical squamocolumnar junction-specific markers define distinct, clinically relevant subsets of low-grade squamous intraepithelial lesions. Am J Surg Pathol. 2013;37:1311-1318.
11. Clifford GM, Smith JS, Aguado T, et al. Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: A meta-Analysis. Br J Cancer. 2003;89:101-105.
12. Smith JS, Lindsay L, Hoots B, et al. Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: A meta-Analysis update. Int J Cancer. 2007;121:621-632.
13. Tjalma WA, Fiander A, Reich O, et al. Differences in human papillomavirus type distribution in high-grade cervical intraepithelial neoplasia and invasive cervical cancer in Europe. Int J Cancer. 2013;132:854-867.
14. Li N, Franceschi S, Howell-Jones R, et al. Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: Variation by geographical region, histological type and year of publication. Int J Cancer. 2011;128:927-935.
15. Safaeian M, Schiffman M, Gage J, et al. Detection of precancerous cervical lesions is differential by human papillomavirus type. Cancer Res. 2009;69:3262-3266.
16. Woodman CB, Collins S, Winter H, et al. Natural history of cervical human papillomavirus infection in young women: A longitudinal cohort study. Lancet. 2001;357:1831-1836.
17. de Sanjose S, Quint WG, Alemany L, et al. Human papillomavirus genotype attribution in invasive cervical cancer: A retrospective cross-sectional worldwide study. Lancet Oncol. 2010;11:1048-1056.
18. Kurman RJ, Schiffman MH, Lancaster WD, et al. Analysis of individual human papillomavirus types in cervical neoplasia: A possible role for type 18 in rapid progression. Am J Obstet Gynecol. 1988;159:293-296.
19. Kalantari M, Karlsen F, Johansson B, et al. Human papillomavirus findings in relation to cervical intraepithelial neoplasia grade: A study on 476 Stockholm women, using PCR for detection and typing of HPV. Hum Pathol. 1997;28:899-904.
20. Bulkmans NW, Bleeker MC, Berkhof J, et al. Prevalence of types 16 and 33 is increased in high-risk human papillomavirus positive women with cervical intraepithelial neoplasia grade 2 or worse. Int J Cancer. 2005;117:177-181.
21. Castle PE, Solomon D, Schiffman M, et al. Human papillomavirus type 16 infections and 2-year absolute risk of cervical precancer in women with equivocal or mild cytologic abnormalities. J Natl Cancer Inst. 2005;97:1066-1071.
22. Bulk S, Berkhof J, Rozendaal L, et al. The contribution of HPV18 to cervical cancer is underestimated using high-grade CIN as a measure of screening efficiency. Br J Cancer. 2007;96:1234-1236.
23. Woodman CB, Collins S, Rollason TP, et al. Human papillomavirus type 18 and rapidly progressing cervical intraepithelial neoplasia. Lancet. 2003;361:40-43.
24. Quint W, Jenkins D, Molijn A, et al. One virus one lesion-individual components of CIN lesions contain a specific HPV type. J Pathol. 2011;227:62-71.
25. Herfs M, Hubert P, Delvenne P. Epithelial metaplasia: Adult stem cell reprogramming and (pre)neoplastic transformation mediated by inflammatioñ Trends Mol Med. 2009;15:245-253.
26. Robboy SJ, Mutter GL, Prat J, et al. Pathology of the Female Reproductive Tract. 2nd ed. Philadelphia: Churchill Livingstone Elsevier; 2009.
27. Marsh M. Original site of cervical carcinoma; topographical relationship of carcinoma of the cervix to the external os and to the squamocolumnar junction. Obstet Gynecol. 1956;7:444-452.
28. Martens JE, Arends J, Van der Linden PJ, et al. Cytokeratin 17 and p63 are markers of the HPV target cell, the cervical stem cell. Anticancer Res. 2004;24:771-775.
29. Traut HF, Papanicolaou GN. Cancer of the uterus: The vaginal smear in its diagnosis. Cal West Med. 1943;59:121-122.
30. Crum CP, Egawa K, Fu YS, et al. Atypical immature metaplasia (AIM). A subset of human papilloma virus infection of the cervix. Cancer. 1983;51:2214-2219.
31. Babawale M, Seth R, Christian A, et al. Histological analysis of cervical intraepithelial neoplasia. Methods Mol Med. 2005;119:41-48.
32. Geng L, Connolly DC, Isacson C, et al. Atypical immature metaplasia (AIM) of the cervix: Is it related to high-grade squamous intraepithelial lesion (HSIL)? Hum Pathol. 1999;30:345-351.
33. Klaes R, Friedrich T, Spitkovsky D, et al. Overexpression of p16(INK4A) as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri. Int J Cancer. 2001;92:276-284.
34. McCluggage WG. Immunohistochemical and functional biomarkers of value in female genital tract lesions. Int J Gynecol Pathol. 2006;25:101-120.
35. McCluggage WG. Immunohistochemistry as a diagnostic aid in cervical pathology. Pathology. 2007;39:97-111.
36. Iaconis L, Hyjek E, Ellenson LH, et al. p16 and Ki-67 immunostaining in atypical immature squamous metaplasia of the uterine cervix: Correlation with human papillomavirus detection. Arch Pathol Lab Med. 2007;131:1343-1349.
37. Skapa P, Robova H, Rob L, et al. p16 immunoprofiles of squamous lesions of the uterine cervix-implications for the reclassification of atypical immature squamous metaplasia. Pathol Oncol Res. 2013;19: 707-714.
38. Darragh TM, Colgan TJ, Thomas Cox J, et al. The Lower Anogenital Squamous Terminology Standardization project for HPV-Associated lesions: Background and consensus recommendations from the College of American Pathologists and the American Society for Colposcopy and Cervical Pathology. Int J Gynecol Pathol. 2013;32:76-115.
39. Smedts F, Ramaekers FC, Vooijs PG. The dynamics of keratin expression in malignant transformation of cervical epithelium: A review. Obstet Gynecol. 1993;82:465.
40. Smedts F, Ramaekers F, Troyanovsky S, et al. Basal-cell keratins in cervical reserve cells and a comparison to their expression in cervical intraepithelial neoplasia. Am J Pathol. 1992;140:601-612.
41. Herfs M, Crum CP. Laboratory management of cervical intraepithelial neoplasia: Proposing a new paradigm. Adv Anat Pathol. 2013;20:86-94.
42. van der Marel J, Quint WG, Schiffman M, et al. Molecular mapping of high-grade cervical intraepithelial neoplasia shows etiological dominance of HPV16. Int J Cancer. 2012;131:E946-E953.
43. Guimera N, Lloveras B, Lindeman J, et al. The occasional role of low-risk human papillomaviruses 6, 11, 42, 44, and 70 in anogenital carcinoma defined by laser capture microdissection/PCR methodology: Results from a global study. Am J Surg Pathol. 2013;37: 1299-1310.
44. Kleter B, van Doorn LJ, ter SJ, et al. Novel short-fragment PCR assay for highly sensitive broad-spectrum detection of anogenital human papillomaviruses. Am J Pathol. 1998;153:1731-1739.
45. van Doorn LJ, Quint W, Kleter B, et al. Genotyping of human papillomavirus in liquid cytology cervical specimens by the PGMY line blot assay and the SPF(10) line probe assay. J Clin Microbiol. 2002;40:979-983.
46. Kleter B, van Doorn LJ, Schrauwen L, et al. Development and clinical evaluation of a highly sensitive PCR-reverse hybridization line probe assay for detection and identification of anogenital human papillomavirus. J Clin Microbiol. 1999;37:2508-2517.
47. Quint WG, Scholte G, van Doorn LJ, et al. Comparative analysis of human papillomavirus infections in cervical scrapes and biopsy specimens by general SPF(10) PCR and HPV genotyping. J Pathol. 2001;194:51-58.
48. Luo W, Yang H, Rathbun K, et al. Detection of human immunodeficiency virus type 1 DNA in dried blood spots by a duplex real-Time PCR assay. J Clin Microbiol. 2005;43:1851-1857.
49. Smedts F, Ramaekers F, Leube RE, et al. Expression of keratins 1, 6, 15, 16, and 20 in normal cervical epithelium, squamous metaplasia, cervical intraepithelial neoplasia, and cervical carcinoma. Am J Pathol. 1993;142:403-412.
50. Miyatake T, Ueda Y, Yoshino K, et al. Clonality analysis and human papillomavirus infection in squamous metaplasia and atypical immature metaplasia of uterine cervix: Is atypical immature metaplasia a precursor to cervical intraepithelial neoplasia 3? Int J Gynecol Pathol. 2007;26:180-187.
51. Schiffman M, Herrero R, Desalle R, et al. The carcinogenicity of human papillomavirus types reflects viral evolution. Virology. 2005;337:76-84.
52. Clifford G, Franceschi S, Diaz M, et al. Chapter 3: HPV typedistribution in women with and without cervical neoplastic diseases. Vaccine. 2006;24(suppl 3):S3/26-34.